Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Uterine Fibroid Treatment Drugs Market to reach USD 3.9 billion by the end of 2030.

Global Uterine Fibroid Treatment Drugs Market Size study & Forecast, By Drug Class (Gonadotropin-releasing Hormone (GnRH) Agonists, Gonadotropin-releasing Hormone (GnRH) Antagonists, Progestin-releasing Intrauterine Device (IUD) & Contraceptives, Non-hormonal Medications, Others), By Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids, Pedunculated Fibroids), By End-user (Hospital Pharmacies, Retail Pharmacies, other) and Regional Analysis, 2023-2030

Product Code: HLSDT-68631289
Publish Date: 1-07-2023
Page: 200

Global Uterine Fibroid Treatment Drugs Market is valued at approximately USD 1.80 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 10.2% over the forecast period 2023-2030. The Uterine Fibroid Treatment Drugs are specifically developed to treat uterine fibroid, which are benign tumors that grow in the uterus. This is a common noncancerous condition affecting the uterus in women of reproductive age. The Uterine Fibroid Treatment Drugs market is being driven by factors such as the increasing number of new product launches and the rising prevalence of uterine fibroids.

These drugs include GnRH agonists, progestin-releasing IUDs, SPRMs, NSAIDs, and tranexamic acid, which aim to reduce fibroid size, manage symptoms such as heavy bleeding and pain, or both. On June 2022, Yselty, an oral GnRH antagonist was authorized by the EMA for the treatment of moderate to severe symptoms of uterine leiomyomas. GnRH antagonist, Myfembree, was authorised by the U.S. FDA for the treatment of heavy bleeding associated with uterine fibroids. along with that on May 2021, Myovant Sciences and Pfizer obtained U.S. FDA approval for Myfembree (relugolix), a medication specifically indicated for the treatment of heavy bleeding associated with uterine fibroids. The effectiveness of these newly launched drugs creates the growth of the market. In addition, the Growing awareness among women about uterine fibroids treatment and various governments working on early fibroids detection and treatment may create lucrative opportunities in the market. However, the high cost of fibroid treatment drugs is hindering the growth of the market.

The key regions considered for the Global Uterine Fibroid Treatment Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising prevalence of uterine fibroids, increasing case of pregnancy complications due to fibroids, and approval of novel treatment options. Asia Pacific is considered the fastest-growing region during the forecasted period due to the presence of two massively populated countries such as India and China. Global companies are entering into agreement with local player for the development and commercialization of therapies in the region.

Major market player included in this report are:
Myovant Sciences GmbH
Pfizer Inc.
Abbvie, Inc.
Ferring B.V.
AstraZeneca
Bayer AG
Amring Pharmaceuticals Inc.
Watson Pharma, Inc.
Boston scientific corporation
Gynesonics Inc.

Recent Developments in the Market:
• On May 2021, Myovant Sciences and Pfizer Inc. announces that the United States Food and Drug Administration (FDA) had approved MYFEMBREE, the first regular or Myfembree (relugolix) is an FDA-approved, once-daily treatment designed to manage heavy menstrual bleeding in premenopausal women with uterine fibroids, and it can be used for up to 24 months.
• On February 2021, Pfizer and Myovant release favorable results from the Phase III LIBERTY 1 and LIBERTY 2 investigations. In women with uterine fibroids, the companies are testing a once-daily combination treatment of relugolix plus estradiol and norethindrone acetate.

Global Uterine Fibroid Treatment Drugs Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Drug class, Type, End user, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug class:
Gonadotropin-releasing Hormone (GnRH) Agonists
Gonadotropin-releasing Hormone (GnRH) Antagonists
Progestin-releasing Intrauterine Device (IUD) & Contraceptives
Non-hormonal Medications
Others

By Type:
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Pedunculated Fibroids

By End user:
Hospital Pharmacies
Retail Pharmacies
Other

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Uterine fibroid treatment drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Uterine fibroid treatment drugs Market, by Drug Class, 2020-2030 (USD Billion)
1.2.3. Uterine fibroid treatment drugs Market, by Type, 2020-2030 (USD Billion)
1.2.4. Uterine fibroid treatment drugs Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Uterine fibroid treatment drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Uterine fibroid treatment drugs Market Dynamics
3.1. Uterine fibroid treatment drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing number of new product launches
3.1.1.2. Rising prevalence of uterine fibroid
3.1.2. Market Challenges
3.1.2.1. High Cost of Uterine fibroid treatment drugs
3.1.3. Market Opportunities
3.1.3.1. Growing awareness of uterine fibroid in women
3.1.3.2. Government focus on early detection of uterine and treatment
Chapter 4. Global Uterine fibroid treatment drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Uterine fibroid treatment drugs Market, by Drug Class
5.1. Market Snapshot
5.2. Global Uterine fibroid treatment drugs Market by Drug Class, Performance – Potential Analysis
5.3. Global Uterine fibroid treatment drugs Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
5.4. Uterine fibroid treatment drugs Market, Sub Segment Analysis
5.4.1. Gonadotropin-releasing Hormone (GnRH) Agonists
5.4.2. Gonadotropin-releasing Hormone (GnRH) Antagonists
5.4.3. Progestin-releasing Intrauterine Device (IUD) & Contraceptives
5.4.4. Non-hormonal Medications
5.4.5. Others
Chapter 6. Global Uterine fibroid treatment drugs Market, by Type
6.1. Market Snapshot
6.2. Global Uterine fibroid treatment drugs Market by Type, Performance – Potential Analysis
6.3. Global Uterine fibroid treatment drugs Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
6.4. Uterine fibroid treatment drugs Market, Sub Segment Analysis
6.4.1. Subserosal Fibroids
6.4.2. Intramural Fibroids
6.4.3. Submucosal Fibroids
6.4.4. Pedunculated Fibroids
Chapter 7. Global Uterine fibroid treatment drugs Market, by End User
7.1. Market Snapshot
7.2. Global Uterine fibroid treatment drugs Market by End User, Performance – Potential Analysis
7.3. Global Uterine fibroid treatment drugs Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
7.4. Uterine fibroid treatment drugs Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Retail pharmacies
7.4.3. Other
Chapter 8. Global Uterine fibroid treatment drugs Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Uterine fibroid treatment drugs Market, Regional Market Snapshot
8.4. North America Uterine fibroid treatment drugs Market
8.4.1. U.S. Uterine fibroid treatment drugs Market
8.4.1.1. Drug Class breakdown estimates & forecasts, 2020-2030
8.4.1.2. Type breakdown estimates & forecasts, 2020-2030
8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Uterine fibroid treatment drugs Market
8.5. Europe Uterine fibroid treatment drugs Market Snapshot
8.5.1. U.K. Uterine fibroid treatment drugs Market
8.5.2. Germany Uterine fibroid treatment drugs Market
8.5.3. France Uterine fibroid treatment drugs Market
8.5.4. Spain Uterine fibroid treatment drugs Market
8.5.5. Italy Uterine fibroid treatment drugs Market
8.5.6. Rest of Europe Uterine fibroid treatment drugs Market
8.6. Asia-Pacific Uterine fibroid treatment drugs Market Snapshot
8.6.1. China Uterine fibroid treatment drugs Market
8.6.2. India Uterine fibroid treatment drugs Market
8.6.3. Japan Uterine fibroid treatment drugs Market
8.6.4. Australia Uterine fibroid treatment drugs Market
8.6.5. South Korea Uterine fibroid treatment drugs Market
8.6.6. Rest of Asia Pacific Uterine fibroid treatment drugs Market
8.7. Latin America Uterine fibroid treatment drugs Market Snapshot
8.7.1. Brazil Uterine fibroid treatment drugs Market
8.7.2. Mexico Uterine fibroid treatment drugs Market
8.8. Middle East & Africa Uterine fibroid treatment drugs Market
8.8.1. Saudi Arabia Uterine fibroid treatment drugs Market
8.8.2. South Africa Uterine fibroid treatment drugs Market
8.8.3. Rest of Middle East & Africa Uterine fibroid treatment drugs Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Myovant Sciences Gmbh
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Pfizer Inc.
9.3.3. Abbvie Inc.
9.3.4. Ferring B.v
9.3.5. AstraZeneca
9.3.6. Bayer AG
9.3.7. Amring Pharmaceuticals Inc.
9.3.8. Watson Pharma Inc.
9.3.9. Boston scientific corporation
9.3.10. Gynesonics Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now